These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32750538)

  • 1. Mass drug administration with azithromycin for trachoma elimination and the population structure of Streptococcus pneumoniae in the nasopharynx.
    Gladstone RA; Bojang E; Hart J; Harding-Esch EM; Mabey D; Sillah A; Bailey RL; Burr SE; Roca A; Bentley SD; Holland MJ
    Clin Microbiol Infect; 2021 Jun; 27(6):864-870. PubMed ID: 32750538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control.
    Bojang E; Jafali J; Perreten V; Hart J; Harding-Esch EM; Sillah A; Mabey DC; Holland MJ; Bailey RL; Roca A; Burr SE
    BMC Microbiol; 2017 Mar; 17(1):75. PubMed ID: 28351345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass administration of azithromycin and Streptococcus pneumoniae carriage: cross-sectional surveys in the Gambia.
    Burr SE; Milne S; Jafali J; Bojang E; Rajasekhar M; Hart J; Harding-Esch EM; Holland MJ; Mabey DC; Sillah A; Bailey RL; Roca A
    Bull World Health Organ; 2014 Jul; 92(7):490-8. PubMed ID: 25110374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment.
    Coles CL; Mabula K; Seidman JC; Levens J; Mkocha H; Munoz B; Mfinanga SG; West S
    Clin Infect Dis; 2013 Jun; 56(11):1519-26. PubMed ID: 23487375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.
    Harding-Esch EM; Holland MJ; Schémann JF; Sillah A; Sarr B; Christerson L; Pickering H; Molina-Gonzalez S; Sarr I; Andreasen AA; Jeffries D; Grundy C; Mabey DCW; Herrmann B; Bailey RL
    Parasit Vectors; 2019 Oct; 12(1):497. PubMed ID: 31640755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical ocular antibiotics induce bacterial resistance at extraocular sites.
    Gaynor BD; Chidambaram JD; Cevallos V; Miao Y; Miller K; Jha HC; Bhatta RC; Chaudhary JS; Osaki Holm S; Whitcher JP; Holbrook KA; Fry AM; Lietman TM
    Br J Ophthalmol; 2005 Sep; 89(9):1097-9. PubMed ID: 16113356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of nasopharyngeal
    Hart JD; Samikwa L; Meleke H; Burr SE; Cornick J; Kalua K; Bailey RL
    Lancet Microbe; 2022 Feb; 3(2):e142-e150. PubMed ID: 35156069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital
    Harrison MA; Harding-Esch EM; Marks M; Pond MJ; Butcher R; Solomon AW; Zhou L; Tan N; Nori AV; Kako H; Sokana O; Mabey DCW; Sadiq ST
    Sex Transm Infect; 2019 Nov; 95(7):522-528. PubMed ID: 30981999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotype Profile of Nasopharyngeal Isolates of
    Hema-Ouangraoua S; Zongo I; Kabore NF; Frédéric N; Yerbanga RS; Tinto H; Compaore YD; Kuepfer I; Chandramohan D; Greenwood B; Ouedraogo JB
    Am J Trop Med Hyg; 2020 Aug; 103(2):679-683. PubMed ID: 32524945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control.
    Seidman JC; Coles CL; Silbergeld EK; Levens J; Mkocha H; Johnson LB; Muñoz B; West SK
    Int J Epidemiol; 2014 Aug; 43(4):1105-13. PubMed ID: 24659584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year.
    Gaynor BD; Holbrook KA; Whitcher JP; Holm SO; Jha HC; Chaudhary JS; Bhatta RC; Lietman T
    Br J Ophthalmol; 2003 Feb; 87(2):147-8. PubMed ID: 12543738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Antibiotic Selection Pressure on the Nasopharyngeal Macrolide Resistome: A Cluster-randomized Trial.
    Keenan JD; Chin SA; Amza A; Kadri B; Nassirou B; Cevallos V; Cotter SY; Zhou Z; West SK; Bailey RL; Porco TC; Lietman TM;
    Clin Infect Dis; 2018 Nov; 67(11):1736-1742. PubMed ID: 29897440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial.
    Skalet AH; Cevallos V; Ayele B; Gebre T; Zhou Z; Jorgensen JH; Zerihun M; Habte D; Assefa Y; Emerson PM; Gaynor BD; Porco TC; Lietman TM; Keenan JD
    PLoS Med; 2010 Dec; 7(12):e1000377. PubMed ID: 21179434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review.
    O'Brien KS; Emerson P; Hooper PJ; Reingold AL; Dennis EG; Keenan JD; Lietman TM; Oldenburg CE
    Lancet Infect Dis; 2019 Jan; 19(1):e14-e25. PubMed ID: 30292480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae.
    Batt SL; Charalambous BM; Solomon AW; Knirsch C; Massae PA; Safari S; Sam NE; Everett D; Mabey DC; Gillespie SH
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2765-9. PubMed ID: 12936971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger.
    Hazel A; Arzika AM; Abdou A; Lebas E; Porco TC; Maliki R; Doan T; Lietman TM; Keenan JD; Blumberg S
    Am J Trop Med Hyg; 2023 Nov; 109(5):1107-1112. PubMed ID: 37783458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae.
    Leach AJ; Shelby-James TM; Mayo M; Gratten M; Laming AC; Currie BJ; Mathews JD
    Clin Infect Dis; 1997 Mar; 24(3):356-62. PubMed ID: 9114185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma.
    Haug S; Lakew T; Habtemariam G; Alemayehu W; Cevallos V; Zhou Z; House J; Ray K; Porco T; Rutar T; Keenan J; Lietman TM; Gaynor BD
    Clin Infect Dis; 2010 Sep; 51(5):571-4. PubMed ID: 20649409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.
    Fry AM; Jha HC; Lietman TM; Chaudhary JS; Bhatta RC; Elliott J; Hyde T; Schuchat A; Gaynor B; Dowell SF
    Clin Infect Dis; 2002 Aug; 35(4):395-402. PubMed ID: 12145722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cross-Sectional Study of the Availability of Azithromycin in Local Pharmacies and Associated Antibiotic Resistance in Communities in Kilosa District, Tanzania.
    Ansah D; Weaver J; Munoz B; Bloch EM; Coles CL; Lietman T; West SK
    Am J Trop Med Hyg; 2019 May; 100(5):1105-1109. PubMed ID: 30915951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.